| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 04/17/2002 | CN1345304A Substituted aniline compounds |
| 04/16/2002 | US6372682 Contacting one or more olefin monomers with a group 8-10 transition metal complex catalyst and optionally a bronsted or lewis acid |
| 04/11/2002 | WO2002028841A2 Reagents for labeling biomolecules having aldehyde or ketone moieties |
| 04/11/2002 | WO2001085671A3 Anthranyl amides and their use as medicaments |
| 04/11/2002 | US20020042510 4-Benzyl-2-hydroxy-1, 4-oxazine-3-one and polymorphic forms thereof |
| 04/11/2002 | US20020042431 Zwitterionic tachykinin receptor antagonists |
| 04/11/2002 | CA2424300A1 Reagents for labeling biomolecules having aldehyde or ketone moieties |
| 04/10/2002 | EP0912567B1 Carboline derivatives |
| 04/10/2002 | EP0882124B1 Cleaning process and composition |
| 04/10/2002 | CN1344259A Processes and intermediates for prepn. of 1,3-diazin-b 6-ones and uracils |
| 04/09/2002 | USRE37650 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| 04/09/2002 | US6369055 Compounds, their preparation and use |
| 04/09/2002 | US6369032 Method for treating allergies |
| 04/04/2002 | WO2002026723A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026722A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/04/2002 | WO2001094301A3 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 04/04/2002 | WO2000063193A9 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them |
| 04/04/2002 | US20020040138 4,4-disubstituted-1, 4-dihydro-2H-3, 1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same |
| 04/04/2002 | US20020040002 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 04/04/2002 | CA2423305A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | CA2423251A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/03/2002 | EP1193260A1 Phenoxazine analogs for the treatment of amyloidosis |
| 04/03/2002 | EP1192465A1 Detection using dendrimers bearing labels and probes |
| 04/03/2002 | EP0948482B1 Method for producing trifluoroacetoacetic acid anilides |
| 04/02/2002 | US6365736 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/02/2002 | CA2059610C 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds, intermediates and a process for the preparation thereof and their use as medicaments |
| 03/29/2002 | CA2357450A1 Phenoxazine analogs useful as amyloid aggregation inhibitors and treatment of alzheimer's disease and disorders related to amyloidosis |
| 03/28/2002 | WO2002024629A1 Zwitterionic tachykinin receptor antagonists |
| 03/28/2002 | WO2001087861A3 Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators |
| 03/28/2002 | WO2001087860A3 Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment |
| 03/28/2002 | US20020037895 Wherein the lactone ring is modified; preventing or treating disorders or diseases mediated by LFA-1 (Leukocyte Function-associated Antigen-1) ICAM-1 (intercellular adhesion molecules) interactions; autoimmune disorders, inflammation |
| 03/28/2002 | CA2423356A1 Zwitterionic tachykinin receptor antagonists |
| 03/27/2002 | EP1191611A2 Piezoelectric element and process for production thereof |
| 03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
| 03/27/2002 | EP0799056B1 Use of a nk-1 receptor antagonist and an opioid analgesic |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362227 Methods for the treatment of tinnitus and other disorders using R(−)ketoptofen |
| 03/26/2002 | US6362200 Antitumor dibenzofluorene derivatives |
| 03/26/2002 | US6362182 Hypotensive agents; anticholesterol agents; benign prostatic hypertropic |
| 03/21/2002 | WO2002022694A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 03/21/2002 | WO2002022572A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 03/21/2002 | WO2002022562A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | US20020035137 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | US20020035108 Method for treating allergies |
| 03/21/2002 | US20020035030 Contacting alpha-olefin with ransition metal complex of and Bronsted or Lewis acid to produce polyolefin |
| 03/21/2002 | CA2422055A1 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 03/21/2002 | CA2421054A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 03/20/2002 | EP1187810A2 Heterocyclic analgesic compounds and their use |
| 03/20/2002 | EP1187592A2 Alpha v integrin receptor antagonists |
| 03/20/2002 | EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/20/2002 | CN1341094A Monoamine reuptake inhibitors for treatment of CNS disorders |
| 03/19/2002 | US6358993 Pharmaceutically active nitrogen ring compounds and methods of use thereof |
| 03/19/2002 | US6358948 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 03/19/2002 | US6358945 Compounds useful as anti-inflammatory agents |
| 03/19/2002 | CA2187114C Method of preparation of delmopinol using substituted isoxazolidines and isoxazolines |
| 03/14/2002 | WO2002020670A1 Oxazine derivatives |
| 03/14/2002 | WO2002020526A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/14/2002 | WO2002020002A2 A method for treating allergies |
| 03/14/2002 | CA2421506A1 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/14/2002 | CA2421502A1 A method for treating allergies |
| 03/13/2002 | EP1186318A2 Combination, for treating depression and anxiety, containing a 5HT1d receptor antagonist and aCNS penetrant NK-1 receptor antagonist |
| 03/13/2002 | EP0975219B1 Fungicide active substance combinations |
| 03/13/2002 | CN1340044A Nervinolin derivatives |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355796 Reacting beta-amino-beta-(perfluoroalkyl)acrylate compound with base and carbamoyl chloride compound to form urea compound, reacting urea compound with phosphorus pentahalide or oxalyl halide |
| 03/12/2002 | US6355655 Treating a cognitive disorder, a neuro-degenerative disorder; age-related dementia; age-induced memory impairment; a movement disorder, attention deficit disorder; attention deficit hyperactivity disorder; psychosis; cognitive deficits |
| 03/12/2002 | CA2006769C 2-and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo [1,2,3,-de] -1,4-benzoxazines useful as analgesic agents |
| 03/07/2002 | WO2002018323A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | WO2002017712A2 Disubstituted benzenes as insecticides |
| 03/07/2002 | WO2001068033A3 Il-8 receptor antagonists |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | CA2416740A1 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/06/2002 | EP0883403A4 Method for treating sexual dysfunctions |
| 03/06/2002 | CA2356797A1 Combination treatment for depression and anxiety |
| 02/28/2002 | WO2001081324B1 Benzoxazine derivatives and benzothiazine derivatives having nos-inhibitory and antioxidant properties |
| 02/28/2002 | WO2001070720A3 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 02/28/2002 | WO2000040569A9 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 02/28/2002 | US20020025960 Heterocycle carboxamides as antiviral agents |
| 02/27/2002 | EP1181282A2 Benzothiazinone and benzoxazinone compounds |
| 02/21/2002 | WO2001072960A3 Il-8 receptor antagonists |
| 02/21/2002 | US20020022725 Reducing N-((S)-(-)- alpha -Methylbenzyl)-3-(S)-(4-fluorophenyl)-1,4-oxazin-2-one; activating with trichloroacetonitrile; coupling with 5-bis(trifluoromethyl)phenyl)ethan-2-ol, hydrogenation |
| 02/21/2002 | US20020022724 Organic initiators and their use in the polymerization of unsaturated monomers |
| 02/21/2002 | US20020022625 Betamimetics having a long-lasting activity, processes for preparing them, and their use as medicaments |
| 02/21/2002 | US20020022615 Cyclic oxyguanidine protease inhibitors |
| 02/21/2002 | DE10038639A1 New and known N-aryl 2-hydroxy-omega-arylalkanamide derivatives, useful e.g. for treating inflammatory diseases such as rheumatism |
| 02/20/2002 | EP1180513A1 Cyclic amide compounds, process for the preparation of the same and uses thereof |
| 02/20/2002 | CN1336930A Bridged heterocyclic derivatives |
| 02/20/2002 | CN1336922A Hypolipidemic and antioxidant morpholine derivatives |
| 02/19/2002 | US6348616 Chemical intermediates for synthesis of desired benzoxazinones |
| 02/14/2002 | WO2002012230A1 Intermediate of carbapenem antibiotics and process for the preparation thereof |
| 02/14/2002 | WO2002012208A1 Nile-red luminescent compound, process for producing the same, and luminescent element utilizing the same |
| 02/14/2002 | WO2002012207A1 Cyclic oxyguanidine protease inhibitors |
| 02/14/2002 | US20020019414 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2002 | US20020019396 Pharmaceutically active morpholinol |
| 02/14/2002 | CA2417914A1 Cyclic oxyguanidine protease inhibitors |
| 02/13/2002 | EP0873333B1 Phenyl benzyl ethers, process for producing them and their use as pesticide and fungicide |
| 02/07/2002 | WO2002010143A1 Non-steroidal inflammation inhibitors |
| 02/07/2002 | WO2002010135A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 02/07/2002 | WO2001000566A3 Substituted phenoxyacetic acids |